The search for a way to reverse molecular aging in human tissue began not in a breakthrough moment, but with a stubborn question and years of determination. Often, that’s exactly how science works.
The source of this damage is a class of compounds called advanced glycation end products, or AGEs, that build up in long-lived proteins like collagen, elastin, and eye lens tissue. The process mirrors what happens when meat browns in a pan, only slower, far more consequential, and until recently, considered permanent.
The path to a solution led researchers to screen vast DNA libraries looking for an enzyme capable of targeting and dismantling the most generic form of this damage, with no naturally occurring enzyme to guide them. It was an enzyme borrowed from a bacterium and enhanced in the laboratory that became the key to reversing the damage.
When tested on human tissue from a 75-year-old donor, results exceeded all expectations. Damage levels dropped to those typically seen in a 30-year-old which for a team that had hoped for twenty percent improvement, the outcome was extraordinary.
The implications reach well beyond aging. People with type 2 diabetes accumulate this damage far faster, making them a compelling early target for an intervention that could clear decades of damage, and for researchers, this is just the beginning.
ARTICLE: REWINDING MOLECULAR AGING
The search for a way to reverse molecular aging in human tissue began not in a breakthrough moment, but with a stubborn question and years of determination. Often, that’s exactly how science works.
The source of this damage is a class of compounds called advanced glycation end products, or AGEs, that build up in long-lived proteins like collagen, elastin, and eye lens tissue. The process mirrors what happens when meat browns in a pan, only slower, far more consequential, and until recently, considered permanent.
The path to a solution led researchers to screen vast DNA libraries looking for an enzyme capable of targeting and dismantling the most generic form of this damage, with no naturally occurring enzyme to guide them. It was an enzyme borrowed from a bacterium and enhanced in the laboratory that became the key to reversing the damage.
When tested on human tissue from a 75-year-old donor, results exceeded all expectations. Damage levels dropped to those typically seen in a 30-year-old which for a team that had hoped for twenty percent improvement, the outcome was extraordinary.
The implications reach well beyond aging. People with type 2 diabetes accumulate this damage far faster, making them a compelling early target for an intervention that could clear decades of damage, and for researchers, this is just the beginning.
ARTICLE: REWINDING MOLECULAR AGING